CAS: 1415925-18-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GSK2795039 REF: TM-T15433CAS: 1415925-18-6 | 98.68% | 72,00 €~874,00 € | Mar 21 May 24 |
 | GSK2795039 REF: AN-AG009CN0CAS: 1415925-18-6 | 97% | 54,00 €~857,00 € | Mar 21 May 24 |
 | GSK2795039 REF: 3D-QGC92518CAS: 1415925-18-6 | Min. 95% | A consultar | Mar 02 Jul 24 |
GSK2795039
CAS:1415925-18-6
GSK2795039 inhibits reactive oxygen species (ROS) production and NADPH consumption. GSK2795039 decreases apoptosis. GSK2795039 is …
Fórmula:
C23H26N6O2S
Pureza:
98.68%
Forma y color:
Solid
Peso molecular:
450.56
Ref: TM-T15433
| 1mg | 72,00 € | |
| 2mg | 95,00 € | |
| 5mg | 158,00 € | |
| 10mg | 239,00 € | |
| 25mg | 420,00 € | |
| 50mg | 613,00 € | |
| 100mg | 874,00 € | |
| 1ml*10 (DMSO) | 171,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
Ref: AN-AG009CN0
| 1mg | 54,00 € | |
| 10mg | 489,00 € | |
| 25mg | 190,00 € | |
| 50mg | 320,00 € | |
| 100mg | 511,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
GSK2795039
CAS:1415925-18-6
GSK2795039 is a molecule that may be a potential therapeutic for hypoxic tumours. GSK2795039 inhibits …
Fórmula:
C23H26N6O2S
Pureza:
Min. 95%
Peso molecular:
450.56 g/mol
Ref: 3D-QGC92518
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 2 de Julio de 2024
